[HTML] frontiersin.org

[HTML][HTML] Application of population pharmacokinetic analysis to characterize CYP2C19 mediated metabolic mechanism of voriconazole and support dose optimization

SC Li, SL Wu, WJ Gong, P Cao, X Chen… - Frontiers in …, 2022 - frontiersin.org
Purpose: The aims of this study were to establish a joint population pharmacokinetic model
for voriconazole and its N-oxide metabolite in immunocompromised patients, to determine …
被引用次数：6 相关文章
[HTML] nih.gov

[HTML][HTML] Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose …

SC Li, SL Wu, WJ Gong, P Cao, X Chen… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Purpose: The aims of this study were to establish a joint population pharmacokinetic model
for voriconazole and its N-oxide metabolite in immunocompromised patients, to determine …

Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization.

S Li, S Wu, W Gong, P Cao, X Chen, W Liu… - Frontiers in …, 2022 - europepmc.org
Purpose: The aims of this study were to establish a joint population pharmacokinetic model
for voriconazole and its N-oxide metabolite in immunocompromised patients, to determine …

Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization

SC Li, SL Wu, WJ Gong, P Cao… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose: The aims of this study were to establish a joint population pharmacokinetic model
for voriconazole and its N-oxide metabolite in immunocompromised patients, to determine …